Search for Clinical Trial Results
Siderosis - 40 Studies Found
Status | Study |
Withdrawn |
Study Name: Treatment of Iron Overload Requiring Chelation Therapy Condition:
|
Enrolling by invitation |
Study Name: A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients. Condition:
Date: 2013-08-07 |
Enrolling by invitation |
Study Name: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood Condition: Central Alveolar Hypoventilation Syndrome Date: 2008-04-01 Interventions: Device: CPAP CPAP treatment for patients with congenital central hypoventilation syndrome |
Completed |
Study Name: Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). Condition: Sickle Cell Disease Date: 2010-03-15 Interventions: Drug: ICL670 Daily doses of ICL670 were taken orally 30 minutes before breakfast. The doses range from 5 |
Completed |
Study Name: A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity Condition: Transfusional Iron Overload Date: 2010-01-05 Interventions: Drug: ICL670 |
Not yet recruiting |
Study Name: Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis Condition: Idiopathic Pulmonary Hemosiderosis Date: 2016-12-03 Interventions: Biological: Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis |
Not yet recruiting |
Study Name: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood Condition: Central Alveolar Hypoventilation Syndrome Date: 2008-04-01 Interventions: Device: CPAP CPAP treatment for patients with congenital central hypoventilation syndrome |
Active, not recruiting |
Study Name: Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis Condition: Superficial Siderosis Date: 2011-01-20 |
Completed |
Study Name: A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product Condition: Siderosis Date: 2007-05-07 Interventions: Other: Observational Trial No intervention is being used in this study. |
Completed |
Study Name: An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study) Condition: Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia Date: 2012-11-26 Interventions: Device: MRI scan MRI was used to measure both liver and cardiac iron loading (R2 by FerriScan and T2*, r |